Manufacturing

Articles

The new reagents are designed to support clinical-phase and commercialization stages of cell and gene therapy production and to enhance DNA transfection.

New Reagents Optimize Biologics Production

A new facility in California will expand Orchard Therapeutic’s capacity to develop and deliver lentiviral vector and gene-corrected hematopoetic stem cells. 

Orchard Therapeutics Announces New Gene Therapy Manufacturing Facility

Cobra, Pall, and Cell and Gene Therapy Catapult are collaborating to develop continuous manufacturing for gene therapy production.

Cobra, Pall, and Partner Receive $1.9 Million to Study Continuous Manufacturing of Adeno-Associated Virus Vectors for Gene Therapy

The new center will integrate biologics drug discovery, development, clinical manufacturing, and commercial manufacturing.

WuXi Biologics Begins Construction of Major Biologics Center in China

The new collaborative center aims to serve as a hub for innovations in drug development and manufacturing.

Lonza Opens New Biomanufacturing Center in Israel

Agnes Shanley is senior editor of Pharmaceutical Technology.

Improving the manufacturing of gene therapy vectors will be crucial to making advanced treatments accessible to more patients who need them, agreed panelists at the 2018 Galien Forum.

Can Gene Therapy Deliver on its Promise?

Experts believe that the contract development and manufacturing organization market will reach $17.38 billion by 2022, with disruptive business models using Industrial Internet of Things (IIot) and single-use technologies proving more profitable and efficient in the long term.

Single-use and IIoT Solutions Expected to Reduce Costs and Enhance Production Efficiency

The new program will provide cell and gene therapy companies a more efficient way to ensure quality compliance across collection center networks and to minimize quality system audit burden on these centers.

Be The Match BioTherapies Launches Program for Faster Cell Facility Onboarding

The expanded Frederick, MD, site will help meet global demand for diagnostic instruments and cell and gene therapies for clinical trials.

Thermo Fisher Opens Newly Expanded Facility in Maryland

New data highlights ability of the SQZ  cell therapy platform to preserve cellular functions.

Manufacturing, Cell Therapies